HDAC inhibitors (IRBM/Merck & Co)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHDAC inhibitors (IRBM/Merck & Co)
Drug Alias NameIRBM-BAIRBM-DIRBM-BIRBM-CMRLB-223 +[7] 
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 1 inhibitorsHistone deacetylase 2 inhibitorsApoptosis stimulants
TargetsHistone deacetylase 2Histone deacetylase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIrbm SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIrbm SPAMerck & Co IncMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A